Dorothea Rudolph
Boehringer Ingelheim (Austria)(AT)
Publications by Year
Research Areas
Cancer-related Molecular Pathways, Microtubule and mitosis dynamics, Biochemical and Molecular Research, Protein Degradation and Inhibitors, Cancer Research and Treatments
Most-Cited Works
- → CREB regulates hepatic gluconeogenesis through the coactivator PGC-1(2001)1,425 cited
- → Severe liver degeneration and lack of NF-κB activation in NEMO/IKKγ-deficient mice(2000)476 cited
- → Pan-KRAS inhibitor disables oncogenic signalling and tumour growth(2023)458 cited
- → BI 6727, A Polo-like Kinase Inhibitor with Improved Pharmacokinetic Profile and Broad Antitumor Activity(2009)391 cited
- → Impaired fetal T cell development and perinatal lethality in mice lacking the cAMP response element binding protein(1998)316 cited
- → Deficits in Memory Tasks of Mice with CREB Mutations Depend on Gene Dosage(1998)211 cited
- → Chemically Induced Degradation of the Oncogenic Transcription Factor BCL6(2017)202 cited
- → Activating Transcription Factor 1 and CREB Are Important for Cell Survival during Early Mouse Development(2002)163 cited
- → Discovery of Novel Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one Compounds as Chemically Stable and Orally Active Inhibitors of the MDM2–p53 Interaction(2016)119 cited
- → DR5 Knockout Mice Are Compromised in Radiation-Induced Apoptosis(2005)115 cited